OliX PharmaceuticalsInc (226950) - Total Liabilities

Latest as of September 2025: ₩44.02 Billion KRW ≈ $29.83 Million USD

Based on the latest financial reports, OliX PharmaceuticalsInc (226950) has total liabilities worth ₩44.02 Billion KRW (≈ $29.83 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 226950 operating cash flow to assess how effectively this company generates cash.

OliX PharmaceuticalsInc - Total Liabilities Trend (2016–2024)

This chart illustrates how OliX PharmaceuticalsInc's total liabilities have evolved over time, based on quarterly financial data. Check OliX PharmaceuticalsInc (226950) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

OliX PharmaceuticalsInc Competitors by Total Liabilities

The table below lists competitors of OliX PharmaceuticalsInc ranked by their total liabilities.

Company	Country	Total Liabilities
Ardagh Metal Packaging SA NYSE:AMBP	USA	$5.79 Billion
Terna Energy Societe Anonyme Commercial Technical Company AT:TENERGY	Greece	€1.50 Billion
Immunome Inc NASDAQ:IMNM	USA	$48.84 Million
Ningbo Boway Alloy Material Co Ltd SHG:601137	China	CN¥11.22 Billion
Washington Federal Inc NASDAQ:WAFD	USA	$24.26 Billion
Easyhome New Retail Group Co Ltd SHE:000785	China	CN¥24.58 Billion
Krungthai Card PCL BK:KTC	Thailand	฿63.35 Billion
Zhejiang Shenghua Biok Biology Co Ltd SHG:600226	China	CN¥1.24 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down OliX PharmaceuticalsInc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is OliX PharmaceuticalsInc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OliX PharmaceuticalsInc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OliX PharmaceuticalsInc (2016–2024)

The table below shows the annual total liabilities of OliX PharmaceuticalsInc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩53.40 Billion ≈ $36.19 Million	+1.74%
2023-12-31	₩52.49 Billion ≈ $35.57 Million	-21.36%
2022-12-31	₩66.74 Billion ≈ $45.23 Million	-2.06%
2021-12-31	₩68.15 Billion ≈ $46.18 Million	+104.71%
2020-12-31	₩33.29 Billion ≈ $22.56 Million	+876.59%
2019-12-31	₩3.41 Billion ≈ $2.31 Million	+387.74%
2018-12-31	₩698.94 Million ≈ $473.66K	-76.42%
2017-12-31	₩2.96 Billion ≈ $2.01 Million	+14.35%
2016-12-31	₩2.59 Billion ≈ $1.76 Million	--

About OliX PharmaceuticalsInc

KQ:226950 Korea Biotechnology

Market Cap

$2.35 Billion

₩3.47 Trillion KRW

Market Cap Rank

#5669 Global

#145 in Korea

Share Price

₩172500.00

Change (1 day)

-6.55%

52-Week Range

₩34800.00 - ₩207000.00

All Time High

₩207000.00